III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and

C Magnani1, C Bianchi, E Chellini

  • 1Dipartimento di Medicina Traslazionale - Università del Piemonte Orientale. corrado.magnani@med.unipmn.it.

La Medicina Del Lavoro
|September 19, 2015
PubMed

Insights

Pleural mesothelioma (MM) incidence is leveling off in Italy, with non-occupational exposure contributing to cases, especially in women. Asbestos removal is slow, and chrysotile remains a confirmed cause of MM.

Area of Science:

  • Epidemiology and Public Health
  • Occupational Medicine
  • Environmental Carcinogenesis

Background:

  • Pleural mesothelioma (MM) incidence trends in Italy show a leveling off, with specific figures for men (3.64/100,000) and women (1.32/100,000) in 2011.
  • Non-occupational exposure accounts for 10% of MM cases, with a notably high incidence in women attributed to both occupational and non-occupational factors.
  • Continued slow removal of asbestos in place indicates ongoing exposure risks.

Framework:

  • Recent literature confirms chrysotile asbestos as a causal agent for MM.
  • Fibrous fluoro-edenite is classified as a Group 1 carcinogen (IARC), and MWCNT-7 Carbon Nanotubes as Group 2B, based on MM data.
  • The latency period for pleural MM is approximately 45 years post-exposure, with incidence trends slowing thereafter, necessitating further research.

Implementation:

  • Both exposure duration and intensity are identified as independent determinants of MM risk.
  • Genetic factors, such as BAP1 germline mutations, are relevant for BAP1 cancer syndrome but not significant for sporadic MM cases.
  • Accurate diagnosis relies on gross tumor appearance, hematoxylin-eosin histology, and specific immunohistochemical markers, guided by morphology and differential diagnosis.

Implications:

  • Recommendations include enhanced collaboration between Cancer Registries and the National Mesothelioma Registry (ReNaM) for systematic case comparison and reporting.
  • Pathologist engagement is crucial for updating diagnostic methodologies, with necroscopy suggested for validation.
  • Health surveillance should encompass all asbestos-related effects, emphasizing risk communication, medical guidance, and smoking cessation; no MM screening tests are recommended.

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
967
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.1K
Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
10.3K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
5.6K
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.4K
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
2.0K